ZURA
Zura Bio Limited
4.10$
-0.7%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -3.6% | -10.3% | +109.4% | -0.2% | -5.0% | -3.9% | -8.5% | -8.8% | -20.8% | +100.7% | -6.7% | |
| – | -3.6% | -10.3% | +109.4% | -0.3% | -5.4% | -3.9% | -8.6% | -9.4% | -21.1% | +102.1% | -7.3% | |
| – | -3.9% | -10.0% | +109.8% | -0.1% | -6.2% | -3.4% | -9.4% | -10.0% | -21.3% | +106.2% | -9.1% | |
| – | -3.9% | -10.0% | +109.8% | -0.1% | -6.2% | -3.4% | -9.4% | -10.0% | -21.3% | +106.2% | -9.1% | |
| – | +12.3% | -23.6% | +7.2% | +4.6% | +7.0% | +8.1% | -11.4% | +36.3% | -51.3% | -5.4% | +38.9% | |
| – | +19.3% | -27.7% | +2.7% | +21.0% | +7.0% | +8.1% | -11.4% | +36.3% | -51.3% | -5.4% | +38.9% | |
| – | +67.1% | -46.0% | -33.3% | +2.4% | -27.7% | +70.4% | -3.5% | +171.8% | -60.9% | +62.9% | +57.6% | |
| – | -6.1% | +2.8% | +156.6% | -2.2% | -4.1% | -5.9% | -8.9% | -14.0% | -6.2% | +113.6% | -9.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.4% | -0.3% | +59.8% | +16.5% | -25.2% | +0.0% | +44.4% | +0.3% | -0.4% | +19.2% | +13.0% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.